NVIDIA Cambridge-1, one of the UK’s most powerful supercomputers, has accelerated research from academia, startups and the UK’s large pharma ecosystem — enabling new approaches to drug development, studies on disease progression, and the advancement of species conservation initiatives.

Now part of NVIDIA DGX™ Cloud, Cambridge-1 will broaden access to AI supercomputing across every industry.